Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cyclophosphamide 2043Radiotherapy 1859Cisplatin 1826Carboplatin 1533Gemcitabine 1435Paclitaxel 1291Bevacizumab 1271Docetaxel 1202pembrolizumab 1201Oxaliplatin 1160Capecitabine 1145Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 864Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 609fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Interventional × Laryngectomy × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡